TrianglePUBLICATIONS · 31358541
Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2019 Oct 15
- First author
- Shusterman S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shusterman S
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Van Ryn C
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Parisi MT
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Servaes S
- type
- Author
- name
- London WB
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Gan J
- type
- Author
- name
- Gillies SD
- type
- Author
- name
- Maris JM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shusterman S
- type
- Author
- name
- Naranjo A
- type
- Author
- name
- Van Ryn C
- type
- Author
- name
- Hank JA
- type
- Author
- name
- Parisi MT
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Servaes S
- type
- Author
- name
- London WB
- type
- Author
- name
- Shimada H
- type
- Author
- name
- Gan J
- type
- Author
- name
- Gillies SD
- type
- Author
- name
- Maris JM
- type
- Author
- bibliography ids
- nci-bib-d52d20c08f1fc1365dae7b2f
- book metadata
- content sha256
- eec17167ee040f6bb6948db3d76a4c0f68aa9db703f23a74aec492079a9fd954
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-19-0798
- electronic publication date
- display
- 2019 Jul 29
- precision
- day
- year
- 2019
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31358541
- immutable id
- pubmed:31358541@eec17167ee040f6bb6948db3d76a4c0f68aa9db703f23a74aec492079a9fd954
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 20
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 6044-6051
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 31358541
- provenance
- batch id
- 23ffe1e2a9e160b6dca0
- provider
- NCBI PubMed ESummary
- record sha256
- 15dea2c2d31d5cf6b3749cd0cdfda5b5c32e6eb8a397eaf9a9a5009ff083e820
- response sha256
- d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
- retrieved at
- 2026-09-09T23:47:44.690737+00:00
- publication date
- display
- 2019 Oct 15
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
Preserved source evidence · Not medical advice